Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasms, Plasma Cell

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

512 public trials 52 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Recruiting

HEME Home Transfusion Program

NCT06487247

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hematologic Malignancy, +14 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Reconstitution in Multiple Myeloma Patients After Autologous Hematopoietic Cell Transplant

NCT06523699

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Recruiting

A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma

NCT07106671

Conditions: CRS - Cytokine Release Syndrome, Cytokine Release Syndrome, Inflammation, +8 more
Locations: Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Recruiting

MYeloma Resistance And Clonal Evolution

NCT03807128

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: La Roche sur Yon Hospital Departmental La Roche-sur-Yon, France

Nantes University Hospital Nantes, France

View Trial Details

Recruiting

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

NCT00935090

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Recruiting

Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory Multiple Myeloma

NCT07032129

Conditions: Autoimmune Diseases, Blood Protein Disorders, Cardiovascular Diseases, +16 more
Locations: District One Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

SBRT Plus Lenalidomide for Solitary Plasmacytoma: Phase II Trial

NCT06863584

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Plasma Cell, +1 more
Locations: 2nd Affiliated Hospital, School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease

NCT04271644

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: 920th Hospital of Joint Logistics Support Force Kunming, Yunnan, China

View Trial Details

Recruiting

a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease

NCT04776330

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: 920th Hospital of Joint Logistics Support Force Kunming, Yunnan, China

View Trial Details

Recruiting

Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma

NCT05597345

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: University of Rochester Rochester, New York, United States

View Trial Details